Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
34,484
+723
+2% +$192K 2.37% 17
2026
Q1
$5.11M Sell
33,761
-6,048
-15% -$734K 1.19% 29
2025
Q4
$4.35M Sell
39,809
-31,507
-44% -$4.58M 0.92% 34
2025
Q3
$10.1M Sell
71,316
-1,117
-2% -$163K 2.1% 19
2025
Q2
$11.7M Buy
72,433
+665
+0.9% +$82.5K 2.58% 14
2025
Q1
$7.66M Sell
71,768
-1,424
-2% -$199K 2.01% 18
2024
Q4
$9.03M Sell
73,192
-891
-1% -$126K 2.11% 19
2024
Q3
$10.6M Buy
74,083
+170
+0.2% +$24.2K 2.51% 14
2024
Q2
$12.1M Buy
73,913
+27,601
+60% +$3.43M 2.93% 10
2024
Q1
$5.79M Buy
+46,312
New +$4.91M 1.48% 31

Other funds holding ARM

Broadleaf Partners's ARM Position: Q2 2026 in Review

Broadleaf Partners increased its Arm (ARM) stake by 2.1% in Q2 2026, buying an estimated $192K and bringing the position to 34,484 shares worth $12.2M. The position accounts for 2.37% of the portfolio, ranked #17.

Broadleaf Partners first reported a position in ARM in Q1 2024 and has held it in 10 quarters since. 956 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • Broadleaf Partners held 34,484 shares of Arm worth $12.2M as of Q2 2026.
  • Broadleaf Partners bought 723 Arm shares in Q2 2026, an estimated $192K.
  • Arm made up 2.37% of Broadleaf Partners's portfolio in Q2 2026, its #17 holding.
  • Broadleaf Partners first reported a position in Arm in Q1 2024 and has held it in 10 quarters since.
  • 956 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on Broadleaf Partners's 13F filing for Q2 2026, filed 13 Aug 2026.